|
|
|
Volumn 15, Issue 2, 2002, Pages 202-204
|
|
Lipids in end-stage renal disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
APOLIPOPROTEIN B;
ATORVASTATIN;
CALCIUM;
CHOLESTEROL;
CHYLOMICRON;
FIBRINOGEN;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN;
HOMOCYSTEINE;
IMMUNOSUPPRESSIVE AGENT;
INTERMEDIATE DENSITY LIPOPROTEIN;
LIPID;
LIPOPROTEIN A;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PHOSPHORUS;
PROTEIN;
TRIACYLGLYCEROL;
VERY LOW DENSITY LIPOPROTEIN;
ATHEROGENESIS;
ATHEROSCLEROSIS;
CHOLESTEROL BLOOD LEVEL;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CORONARY ARTERY DISEASE;
DIABETES MELLITUS;
DISEASE COURSE;
DISEASE MARKER;
DRUG EFFECT;
HEART DEATH;
HEMODIALYSIS;
HIGH RISK POPULATION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTRIGLYCERIDEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FAILURE;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LIPID BLOOD LEVEL;
MORTALITY;
OUTCOMES RESEARCH;
POPULATION RESEARCH;
RISK ASSESSMENT;
TRIACYLGLYCEROL BLOOD LEVEL;
CHRONIC KIDNEY FAILURE;
HYPERLIPIDEMIA;
PHYSIOLOGY;
RENAL REPLACEMENT THERAPY;
REVIEW;
GEMFIBROZIL;
HUMAN;
HYPERLIPIDEMIA;
KIDNEY FAILURE, CHRONIC;
LIPOPROTEINS, LDL CHOLESTEROL;
RENAL DIALYSIS;
CHOLESTEROL, LDL;
HUMANS;
HYPERLIPIDEMIAS;
|
|
EID: 0035988268
PISSN: 11218428
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (9)
|
